Members |
targetComponentId |
Poisoning caused by skeletal muscle relaxant |
Skeletal muscle relaxant overdose |
Poisoning caused by skeletal muscle relaxant |
Adverse reaction to skeletal muscle relaxants |
Poisoning caused by spinal anesthetic |
Local anaesthetic agent overdose |
Poisoning caused by spinal anesthetic |
Local anesthetic drug adverse reaction |
Poisoning caused by tetracycline group antibiotic |
Tetracycline antibacterial overdose (disorder) |
Poisoning caused by tetracycline group antibiotic |
Tetracyclines group adverse reaction |
Poisoning caused by vaginal contraceptive |
Poisoning caused by drug AND/OR medicinal substance (disorder) |
Poisoning caused by vasodilator |
Vasodilator adverse reaction |
Poisoning caused by vasodilator |
Vasodilator overdose |
Poisoning due to other venomous animals or plants |
Toxic effect of venom |
intoxication causée par des animaux venimeux marins ou des plantes vénéneuses marines |
Toxic effect of venom |
Poisoning: [antiParkinsonian drug] &/or [anticonvulsant] |
Adverse reaction to antiparkinsonism drug |
Poisoning: [antiParkinsonian drug] &/or [anticonvulsant] |
Overdose of anticonvulsant drug |
Poisoning: [antiallergic] &/or [antiemetic ] or [antihistamine] |
Adverse reaction to antihistamines |
Poisoning: [antiallergic] &/or [antiemetic ] or [antihistamine] |
Overdose of histamine receptor antagonist (disorder) |
Poisoning: [antiallergic] &/or [antiemetic ] or [antihistamine] |
Antiemetic adverse reaction |
Poisoning: [antiallergic] &/or [antiemetic ] or [antihistamine] |
Antiemetic overdose |
Poisoning: [antineoplastic] &/or [immunosuppressive] |
Antineoplastic overdose |
Poisoning: [antineoplastic] &/or [immunosuppressive] |
Immunosuppressant adverse reaction |
Poisoning: [antineoplastic] &/or [immunosuppressive] |
Immunosuppressant overdose |
Poisoning: [antineoplastic] &/or [immunosuppressive] |
Antineoplastic adverse reaction |
Poisoning: [psychostimulant] or [stimulant] |
Psychostimulant overdose |
Poisoning: [water, mineral and urate metabolism] or [diuretic] |
Diuretic adverse reaction |
Poisoning: [water, mineral and urate metabolism] or [diuretic] |
Diuretic overdose |
tableau social précaire |
Social context finding |
tableau social précaire |
Social and personal history finding |
poplité |
Popliteal region structure |
Positive contrast meatogram |
Computed tomography of internal auditory meatus with contrast (procedure) |
Positive contrast meatogram |
Magnetic resonance imaging of internal auditory meatus with contrast (procedure) |
Posterior axillary |
Posterior axillary fold structure |
Posterior axillary |
Axillary region structure |
Postoperative pancreatography |
Imaging of pancreas with contrast (procedure) |
Postoperative pancreatography |
Fluoroscopic pancreatography with contrast (procedure) |
Postoperative pancreatography |
Computed tomography of pancreas with contrast (procedure) |
Postoperative pancreatography |
Endoscopic retrograde pancreatography |
Postoperative pancreatography |
Magnetic resonance imaging of pancreas with contrast (procedure) |
Potassium in sample |
Potassium level - finding |
Potassium sparing diuretic poisoning |
Potassium sparing diuretic overdose |
Potassium sparing diuretic poisoning |
Potassium sparing diuretic adverse reaction |
Potassium sparing diuretic poisoning of undetermined intent |
Potassium sparing diuretic overdose |
Potassium sparing diuretic poisoning of undetermined intent |
Potassium sparing diuretic adverse reaction |
Presenting complaint |
Chief complaint (observable entity) |
Presenting complaint |
Chief complaint (observable entity) |
Presenting complaint |
Chief complaint section (record artifact) |
Presenting complaint |
Chief complaint section (record artifact) |
Presenting complaint |
Chief complaint (observable entity) |
Presenting complaint |
Chief complaint section (record artifact) |
Primary malignant neoplasm of breast with axillary lymph node invasion |
Primary malignant neoplasm of breast (disorder) |
Primary malignant neoplasm of breast with axillary lymph node invasion |
Metastatic malignant neoplasm to axillary lymph nodes |
Primary malignant neoplasm of ovary, with widespread metastatic disease |
Widespread metastatic malignant neoplastic disease (disorder) |
Primary malignant neoplasm of ovary, with widespread metastatic disease |
Primary malignant neoplasm of ovary |
néoplasme malin primitif de la prostate métastasée dans un os |
Metastatic malignant neoplasm to bone |
néoplasme malin primitif de la prostate métastasée dans un os |
Primary malignant neoplasm of prostate |
Primary malignant neoplasm of rectosigmoid junction metastatic to brain |
Metastatic malignant neoplasm to brain |
Primary malignant neoplasm of rectosigmoid junction metastatic to brain |
Primary malignant neoplasm of rectosigmoid junction |
Primary malignant neoplasm of thyroid gland, metastatic to bone |
Metastatic malignant neoplasm to bone |
Primary malignant neoplasm of thyroid gland, metastatic to bone |
Primary malignant neoplasm of thyroid gland |
Primary malignant neoplasm of vulva, with widespread metastatic disease |
Primary malignant neoplasm of vulva |
Primary malignant neoplasm of vulva, with widespread metastatic disease |
Widespread metastatic malignant neoplastic disease (disorder) |
difficultés liées à l'environnement social |
Social context finding |
difficultés liées à l'environnement social |
Social environment related disease |
difficultés liées à l'environnement social |
Social and personal history finding |
intervention facilitant le diagnostic |
Procedure |
Procedure aiding diagnosis |
Procedure |
intervention facilitant le diagnostic |
Determination of a value, conclusion, or inference by evaluating evidence |
Procedure aiding diagnosis |
Determination of a value, conclusion, or inference by evaluating evidence |
Procedure related to surgical arteriovenous connection |
Arteriovenous fistula operation |
Procedure related to surgical arteriovenous connection |
Arteriovenous anastomosis |
Procedure related to surgical arteriovenous connection |
Procedure on blood vessel |
Product containing aspirin and isosorbide (medicinal product) |
Product containing aspirin and isosorbide mononitrate (medicinal product) |
Product containing benzimidazole and anthelmintic |
Anthelmintic |
Product containing benzimidazole and anthelmintic |
Benzimidazole (substance) |
immunoglobuline anti-Rh>o<(D) |
Product containing human anti-D immunoglobulin (medicinal product) |
Product containing blood group antibody D in parenteral dose form (medicinal product form) |
Product containing human anti-D immunoglobulin in parenteral dose form (medicinal product form) |
Product containing collodion |
A liquid dose form consisting of active substance(s) in a mixture of pyroxylin or similar in ether and ethanol. |
Product containing diamidine and antiprotozoal |
Antiprotozoal |
Product containing diamidine and antiprotozoal |
Diamidine (substance) |
Product containing dichloroacetamide and antiprotozoal |
Antiprotozoal |
Product containing dichloroacetamide and antiprotozoal |
Dichloroacetamide (substance) |
Product containing hydralazine and isosorbide |
Product containing hydralazine and isosorbide dinitrate (medicinal product) |
Product containing hydralazine and isosorbide in oral dose form (medicinal product form) |
Hydralazine- and isosorbide dinitrate-containing product in oral dose form |
Product containing hydroxyquinoline and antiprotozoal |
Oxyquinoline |
Product containing hydroxyquinoline and antiprotozoal |
Antiprotozoal |
Product containing isosorbide in oromucosal dose form (medicinal product form) |
Isosorbide dinitrate-containing product in oromucosal dose form |
Product containing isosorbide in oropharyngeal dose form (medicinal product form) |
Isosorbide dinitrate-containing product in oromucosal dose form |
Product containing isosorbide in parenteral dose form (medicinal product form) |
Isosorbide dinitrate-containing product in parenteral dose form |
Product containing isosorbide in sublingual dose form (medicinal product form) |
Isosorbide dinitrate-containing product in oromucosal dose form |
Product containing isosorbide in transdermal dose form (medicinal product form) |
Isosorbide dinitrate-containing product in transdermal dose form |
Product containing only aspirin and isosorbide (medicinal product) |
Aspirin and isosorbide mononitrate only product |
Product containing only blood group antibody D (medicinal product) |
Product containing only human anti-D immunoglobulin in parenteral dose form (medicinal product form) |
Product containing only blood group antibody D in parenteral dose form (medicinal product form) |
Product containing only human anti-D immunoglobulin in parenteral dose form (medicinal product form) |
Product containing only collodion (medicinal product) |
A liquid dose form consisting of active substance(s) in a mixture of pyroxylin or similar in ether and ethanol. |
Product containing only hydralazine and isosorbide (medicinal product) |
Product containing only hydralazine and isosorbide dinitrate (medicinal product) |
Product containing only hydralazine and isosorbide in oral dose form (medicinal product form) |
Product containing only hydralazine and isosorbide dinitrate in oral dose form (medicinal product form) |
Product containing only isosorbide in oromucosal dose form (medicinal product form) |
Isosorbide dinitrate only product in oromucosal dose form |
Product containing only isosorbide in parenteral dose form (medicinal product form) |
Isosorbide dinitrate only product in parenteral dose form |
Product containing only isosorbide in transdermal dose form (medicinal product form) |
Isosorbide dinitrate only product in transdermal dose form |
Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 10 milligram/1 each conventional release oral tablet |
Amitriptyline (as amitriptyline hydrochloride) 12.5 mg and chlordiazepoxide 10 mg oral tablet |
Product containing precisely amitriptyline hydrochloride 12.5 milligram and chlordiazepoxide 5 milligram/1 each conventional release oral tablet |
Product containing precisely amitriptyline (as amitriptyline hydrochloride) 12.5 milligram and chlordiazepoxide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Product containing precisely blood group antibody D 1136 unit/1 milliliter conventional release solution for injection (clinical drug) |
Product containing precisely human anti-D immunoglobulin 1136.364 unit/1 milliliter conventional release solution for injection (clinical drug) |
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection (clinical drug) |
Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |